Date | Time | Source | Headline | Symbol | Company |
05/13/2024 | 1:03AM | Alliance News | Microsoft, Amazon to invest billions in French tech | LSE:0R1O | Amazon.com Inc |
05/13/2024 | 1:03AM | Alliance News | Microsoft, Amazon to invest billions in French tech | LSE:0QYP | Microsoft Corp |
05/13/2024 | 1:01AM | GlobeNewswire Inc. | Norsk Hydro: New Hydro CEO accelerating growth, value creation and sustainability to change the game for aluminium | TG:NHY | Lucapa Diamond Company Ltd |
05/13/2024 | 1:01AM | GlobeNewswire Inc. | Norsk Hydro: New Hydro CEO accelerating growth, value creation and sustainability to change the game for aluminium | TG:A2R0MA | Norsk Hydro ASA |
05/13/2024 | 1:00AM | GlobeNewswire Inc. | Corbion reports the progress of its € 20 million share buyback program 6 May – 10 May 2024 | EU:CRBN | Corbion N.V. |
05/13/2024 | 1:00AM | GlobeNewswire Inc. | Communiqué de presse : Sanofi investit plus d’un milliard d’euros supplémentaires dans la production de médicaments en France, en plus des 2,5 milliards d’euros déjà engagés dans de grands projets de souveraineté sanitaire | BIT:1SAN | Sanofi |
05/13/2024 | 1:00AM | GlobeNewswire Inc. | Air France-KLM a remboursé les 48 millions d'euros restants d'OCEANE à échéance 2026 | TG:AFR | Air France KLM |
05/13/2024 | 1:00AM | GlobeNewswire Inc. | Air France-KLM a remboursé les 48 millions d'euros restants d'OCEANE à échéance 2026 | LSE:AIRF | Air France-Klm |
05/13/2024 | 1:00AM | GlobeNewswire Inc. | Press Release: Sanofi adds over €1 billion for biomanufacturing to €2.5 billion already committed in major projects in France to support health sovereignty | BIT:SANF | Sanofi |
05/13/2024 | 1:00AM | GlobeNewswire Inc. | Dupixent® (dupilumab) sBLA Accepted for FDA Priority Review for Treatment of Adolescents with Chronic Rhinosinusitis with Nasal Polyposis (CRSwNP) | NASDAQ:SNY | Sanofi |
05/13/2024 | 1:00AM | GlobeNewswire Inc. | Dupixent® (dupilumab) sBLA Accepted for FDA Priority Review for Treatment of Adolescents with Chronic Rhinosinusitis with Nasal Polyposis (CRSwNP) | NASDAQ:REGN | Regeneron Pharmaceuticals Inc |
05/13/2024 | 1:00AM | GlobeNewswire Inc. | Valneva Reports Further Positive Pivotal Phase 3 Data in Adolescents for its Single-Shot Chikungunya Vaccine | TG:AYJ | Valneva SE |
05/13/2024 | 1:00AM | GlobeNewswire Inc. | Norsk Hydro: Changes in Hydro’s Executive Leadership Team | TG:A2R0MA | Norsk Hydro ASA |
05/13/2024 | 1:00AM | GlobeNewswire Inc. | Valneva annonce de nouveaux résultats positifs chez les adolescents pour l’étude pivot de Phase 3 de son vaccin à dose unique contre le chikungunya | TG:AYJ | Valneva SE |
05/13/2024 | 1:00AM | GlobeNewswire Inc. | Communiqué de presse : Sanofi investit plus d’un milliard d’euros supplémentaires dans la production de médicaments en France, en plus des 2,5 milliards d’euros déjà engagés dans de grands projets de souveraineté sanitaire | TG:SNW | Sanofi |
05/13/2024 | 1:00AM | GlobeNewswire Inc. | Valneva Reports Further Positive Pivotal Phase 3 Data in Adolescents for its Single-Shot Chikungunya Vaccine | EU:VLA | Valneva SE |
05/13/2024 | 1:00AM | GlobeNewswire Inc. | Valneva annonce de nouveaux résultats positifs chez les adolescents pour l’étude pivot de Phase 3 de son vaccin à dose unique contre le chikungunya | EU:VLA | Valneva SE |
05/13/2024 | 1:00AM | GlobeNewswire Inc. | Norsk Hydro: Changes in Hydro’s Executive Leadership Team | TG:NHY | Lucapa Diamond Company Ltd |
05/13/2024 | 1:00AM | GlobeNewswire Inc. | Valneva Reports Further Positive Pivotal Phase 3 Data in Adolescents for its Single-Shot Chikungunya Vaccine | LSE:0OB3 | Valneva Se |
05/13/2024 | 1:00AM | GlobeNewswire Inc. | Valneva Reports Further Positive Pivotal Phase 3 Data in Adolescents for its Single-Shot Chikungunya Vaccine | EU:VLA | Valneva SE |
05/13/2024 | 1:00AM | GlobeNewswire Inc. | Dupixent® (dupilumab) sBLA Accepted for FDA Priority Review for Treatment of Adolescents with Chronic Rhinosinusitis with Nasal Polyposis (CRSwNP) | EU:SAN | Sanofi |
05/13/2024 | 1:00AM | GlobeNewswire Inc. | Corbion reports the progress of its € 20 million share buyback program 6 May – 10 May 2024 | TG:CSUA | Corbion N.V. |
05/13/2024 | 1:00AM | GlobeNewswire Inc. | Start of Day Message | | |
05/13/2024 | 1:00AM | GlobeNewswire Inc. | Valneva annonce de nouveaux résultats positifs chez les adolescents pour l’étude pivot de Phase 3 de son vaccin à dose unique contre le chikungunya | LSE:0OB3 | Valneva Se |
05/13/2024 | 1:00AM | GlobeNewswire Inc. | Communiqué de presse : Sanofi investit plus d’un milliard d’euros supplémentaires dans la production de médicaments en France, en plus des 2,5 milliards d’euros déjà engagés dans de grands projets de souveraineté sanitaire | BIT:SANF | Sanofi |
05/13/2024 | 1:00AM | GlobeNewswire Inc. | Press Release: Sanofi adds over €1 billion for biomanufacturing to €2.5 billion already committed in major projects in France to support health sovereignty | TG:SNW | Sanofi |
05/13/2024 | 1:00AM | Business Wire | CTP doubles in size only three years after Euronext listing | | |
05/13/2024 | 1:00AM | GlobeNewswire Inc. | Air France-KLM a remboursé les 48 millions d'euros restants d'OCEANE à échéance 2026 | BIT:AF | Air France KLM |
05/13/2024 | 1:00AM | GlobeNewswire Inc. | Press Release: Sanofi adds over €1 billion for biomanufacturing to €2.5 billion already committed in major projects in France to support health sovereignty | EU:SAN | Sanofi |
05/13/2024 | 1:00AM | GlobeNewswire Inc. | Air France-KLM repaid remaining €48 million of OCEANE 2026 bonds | BIT:AF | Air France KLM |